CD274 and hepatocellular carcinoma: Functionally, in patient-derived and murine HCC models, TREM2 loss restored CD8+ T-cell infiltration and potentiated anti-PD-L1 efficacy, nominating TREM2+ TAMs as actionable suppressors (with particular enrichment after TACE) [36].